CXCL10 mediates CD8+ T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer-Reference-Cited by-同舟云学术

CXCL10 mediates CD8+ T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer

Published:2023-07 Issue: Volume:567 Page:216263
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Yan Wei^ORCID,Qiu Lin,Yang Meiling,Xu Anran,Ma Manqi,Yuan Qinzi,Ma Xiaochen,Liang Wenjuan,Li Xuenong,Lu Yanxia

Funder

National Natural Science Foundation of China

Basic and Applied Basic Research Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. Cancer treatment and survivorship statistics, 2022;Miller;CA A Cancer J. Clin.,2022

2. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N. Engl. J. Med.,2004

3. The complexity of translating anti-angiogenesis therapy from basic science to the clinic;Ye;Dev. Cell,2016

4. Rechallenge for patients with RAS and BRAF wild-type metastatic colorectal cancer with acquired resistance to first-line cetuximab and irinotecan: a phase 2 single-arm clinical trial;Cremolini;JAMA Oncol.,2019

5. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment;Yi;Mol. Cancer,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Open‐Source Throttling of CD8⁺ T Cells in Brain with Low‐Intensity Focused Ultrasound‐Guided Sequential Delivery of CXCL10, IL‐2, and aPD‐L1 for Glioblastoma Immunotherapy;Advanced Materials;2024-09-12

2. Signaling molecules in the microenvironment of hepatocellular carcinoma;Functional & Integrative Genomics;2024-08-29

3. Optimizing the spatial immune landscape of CD103+CD8+ tissue-resident memory T cells in non-small cell lung cancer by neoadjuvant chemotherapy;Cellular Oncology;2024-08-19

4. Establishment of a chemokine-based prognostic model and identification of CXCL10+ M1 macrophages as predictors of neoadjuvant therapy efficacy in colorectal cancer;Frontiers in Immunology;2024-08-07

5. Monocyte/Macrophage‐Mediated Transport of Dual‐Drug ZIF Nanoplatforms Synergized with Programmed Cell Death Protein‐1 Inhibitor Against Microsatellite‐Stable Colorectal Cancer;Advanced Science;2024-08-05